Barriers and Opportunities of Oncofertility Practice in Nine Developing Countries and the Emerging Oncofertility Professional Engagement Network.
Journal
JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170
Informations de publication
Date de publication:
2020
2020
Historique:
accepted:
29
09
2018
entrez:
8
4
2020
pubmed:
8
4
2020
medline:
29
7
2021
Statut:
epublish
Résumé
Oncofertility practice continues to grow in developing countries despite the lack of health care services, especially those related to cancer care. The purpose of this study is to further explore oncofertility practice in these countries and identify opportunities for field-wide coalescence. We generated a survey to learn more about oncofertility practice in nine developing countries within our Oncofertility Consortium Global Partners Network-Mexico, Colombia, Guatemala, Argentina, Chile, Nigeria, South Africa, Saudi Arabia, and India. Their responses were collected, reviewed, and discussed. Surveyed centers from the nine developing countries continue to experience a similar set of common challenges, including a lack of awareness among providers and patients, cultural and religious constraints, lack of insurance coverage and funding to help to support oncofertility programs, and high out-of-pocket costs for patients. Despite these barriers, many opportunities exist and there is great potential for the future. The current need is to unify the new technologies and best practices that emerge from rural communities and developing countries with those in large metropolitan cities, both domestically (US based) and abroad, into a functional unit: the Oncofertility Professional Engagement Network. The Oncofertility Professional Engagement Network will bridge the gap between domestic and international programs to establish a strong global network in which members share resources, methodologies and experiences and further build cultural competency.
Identifiants
pubmed: 32259158
doi: 10.1200/JGO.18.00180
pii: 1800180
pmc: PMC7853876
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NICHD NIH HHS
ID : P50 HD076188
Pays : United States
Commentaires et corrections
Type : ErratumIn
Type : RepublishedIn
Informations de copyright
© 2020 by American Society of Clinical Oncology.
Références
JCO Glob Oncol. 2020 Mar 2;6:
pubmed: 32259160
Ann Oncol. 2013 Oct;24 Suppl 6:vi160-70
pubmed: 23813932
Fertil Steril. 2013 Nov;100(5):1214-23
pubmed: 24011612
J Pediatr Oncol Nurs. 2014 Jul;31(4):211-222
pubmed: 24799444
Am Behav Sci. 2015 May 1;59(5):548-564
pubmed: 26576061
Pediatrics. 2008 May;121(5):e1461-9
pubmed: 18450888
J Assist Reprod Genet. 2012 Jun;29(6):479-87
pubmed: 22614159
J Clin Oncol. 2018 Jul 1;36(19):1994-2001
pubmed: 29620997
Arch Gynecol Obstet. 2018 Jan;297(1):257-267
pubmed: 29181578
J Glob Oncol. 2016 Apr;2(2):83-96
pubmed: 27284576
J Assist Reprod Genet. 2012 Jun;29(6):469-72
pubmed: 22614158
J Assist Reprod Genet. 2012 Jun;29(6):465-8
pubmed: 22648282
Ann Oncol. 2010 May;21 Suppl 5:v266-73
pubmed: 20555095
Fertil Steril. 2013 Nov;100(5):1224-31
pubmed: 24094423
JCO Glob Oncol. 2020 Mar 2;6:
pubmed: 32259156
Nat Rev Clin Oncol. 2010 Aug;7(8):466-75
pubmed: 20498666
J Adolesc Young Adult Oncol. 2013 Mar;2(1):25-30
pubmed: 23610740
J Assist Reprod Genet. 2012 Jun;29(6):473-7
pubmed: 22562284
JCO Glob Oncol. 2020 Mar 2;6:
pubmed: 32259159
J Clin Oncol. 2006 Jun 20;24(18):2917-31
pubmed: 16651642
J Clin Oncol. 2013 Jul 1;31(19):2500-10
pubmed: 23715580
Arch Gynecol Obstet. 2018 Jan;297(1):241-255
pubmed: 29177593
J Natl Compr Canc Netw. 2018 Jan;16(1):66-97
pubmed: 29295883